跳至主要内容
临床试验/NCT03924505
NCT03924505已完成不适用

Preventing Opioid Overdose Mortality in the United States

RTI International2 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2019年9月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
105
试验地点
2
主要终点
Naloxone Coverage (Consistency)

研究概览

简要总结

This study aims to conduct a randomized controlled trial of 105 syringe services programs (SSPs) throughout the United States to understand the effectiveness of a multifaceted, facilitation-based strategy at advancing naloxone implementation effectiveness within SSPs. Together, these efforts can improve access to naloxone for people at high risk of overdose, thereby improving our nation's response to the opioid overdose epidemic.

详细描述

We conducted a randomized controlled trial of SSPs throughout the United States (US) and US Territories. Prior to the trial, 342 SSPs were known to be operating throughout the US and US Territories. Our team launched a national survey of syringe services programs (NSSSP) in February 2019 of all known SSPs operating throughout the United States and its Territories, receiving a response from 263 (77%) SSPs. Among the responding SSPs, 94% were implementing overdose education and naloxone distribution (OEND), and a total of 105 of SSPs implementing OEND were recruited into the trial. SSPs were randomized in a 1-to-1 fashion to either receive the OEND best practice recommendations (comparison SSPs) or the OEND best practice recommendations along with facilitation-based implementation strategies as detailed below (intervention SSPs).

We tested the effectiveness of a multifaceted, facilitation-based strategy at advancing OEND implementation effectiveness within SSPs. Implementation effectiveness is 'an organization-level construct that refers to the aggregated consistency, quality, and appropriateness of innovation use (OEND) within an organization (SSP).'

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

盲法说明

Study statistician was masked to which participants were in the intervention arm and which participants were in the control arm.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Naloxone Coverage (Consistency)

时间窗: 3 months

Mean number of syringe services program participants receiving naloxone per total number of syringe services program participants

Naloxone Doses Distributed (Consistency)

时间窗: 3 months

The mean number of naloxone doses distributed per total number of SSP participants

Best Practice Adoption (Implementation Quality)

时间窗: 12 months

The mean number of best practices adopted by the SSP

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barrot Lambdin

Fellow

RTI International

研究点 (2)

Loading locations...

相似试验

Preventing Opioid Overdose Mortality in the United... | 临床试验